UK government secures additional 40 million doses of Valneva vaccine
The latest deal will bolster long-term vaccine production in Scotland and brings the total UK vaccine portfolio to 407 million doses over the next two years. Valneva’s coronavirus vaccine candidate is currently in phase I/II trials and will require MHRA approval.
Source:
Department of Health and Social Care